NASDAQ · Medical - Pharmaceuticals

HKPD (HKPD) Stock

$0.44 +8.48% NASDAQ: HKPD Healthcare

Valuation

MetricValue
Price$0.44
Market Cap$4.86M
P/E Ratio-6.64
P/B Ratio0.97
P/S Ratio0.30
EPS (TTM)$0.00
52-Week High$2.58
52-Week Low$0.31
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-13.85%
ROA-7.29%
ROCE-10.00%
Gross Margin11.89%
Operating Margin0.65%
Net Margin-4.29%
Debt/Equity0.44
Current Ratio3.00

Annual Financials (USD)

Metric202320242025
Revenue$13.0M$17.0M$20.0M
Operating Profit$1.0M$2.0M$0
Net Profit$1.0M$1.0M$0
EPS$0.09$0.18$0.00
Op Margin8.3%9.6%0.7%

Balance Sheet (USD)

Metric202320242025
Total Assets$3.0M$9.0M$9.0M
Total Liabilities$3.0M$4.0M$4.0M
Cash$1.0M$1.0M$1.0M
Borrowings$1.0M$2.0M$2.0M

Latest News

Top Premarket Decliners MT Newswires · Jul 17, 2026 Cellyan Biotechnology Gets 180-Day Nasdaq Grace Period on Bid-Price Rule MT Newswires · Jul 16, 2026 Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period GlobeNewswire · Jul 16, 2026 Cellyan Biotechnology Files $200 Million Mixed Shelf MT Newswires · Jun 12, 2026

Cash Flow (USD)

Metric202320242025
Operating Cash Flow$2.0M$0$1.0M
Investing Cash Flow$0$0$-3.0M
Financing Cash Flow$0$0$-1.0M
Net Cash Flow$0$0$0
Free Cash Flow$2.0M$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.05
EV / EBITDA-13.20
FCF Yield-9.90%
Quick Ratio2.73
Interest Coverage-13.84
Return 1Y-66.62%
Return 3Y—
Return 5Y—

Ownership

Insiders Held33.13%
Institutions Held0.32%
Institutions Float Held0.47%
Institutional HolderSharesReport Date
Stonex Group Inc.39,3952026-03-31
Clear Street Group Inc.12,0192026-03-31
Two Sigma Investments, LP10,8322026-03-31
UBS Group AG1102026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About HKPD

HKPD is led by CEO Chenyu Liang, employs 27 people, headquartered in HK, publicly traded since 2025.

HKPD stock trades at $0.44 with a market capitalization of $4.86M. The stock is valued at a price-to-earnings (P/E) ratio of -6.64, price-to-book of 0.97, price-to-sales of 0.30. Over the past 52 weeks the stock has ranged between $0.31 and $2.58, and currently trades 82.9% below its 52-week high.

On profitability, HKPD generates a return on equity (ROE) of -13.85%, return on capital employed of -10.00%, an operating margin of 0.65%, a net profit margin of -4.29%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides